首页行业分类生物医药生物2023-07-14-中国银河-天坛生物-2023H1业绩快报点评:业绩略超预期,Q2血制品高景气延续
PDF

2023-07-14-中国银河-天坛生物-2023H1业绩快报点评:业绩略超预期,Q2血制品高景气延续

娣玲3页772.82K

下载文档
/3
全屏查看
2023-07-14-中国银河-天坛生物-2023H1业绩快报点评:业绩略超预期,Q2血制品高景气延续
还有 3 页未读 ,您可以 继续阅读 或 下载文档
报告派所有资源均由用户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1、本文档共计 3 页,下载后文档不带水印,支持完整阅读内容或进行编辑。
2、当您下载文档后,并不意味着拥有了版权,文档仅供网友学习交流,不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!
4、本本所有内容不构成任何投资建议,不具有任何指导和买卖意见。
5、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。
中国银河证券研究院CHINA GALAXY SECURITIES报表预测2023E2024E2025E2023E2024E2025E7270.717540.358216199498.74营业收入4261.305372.126155.957530.79现金3712.893813.363969.444425.89营业成本2170.022710.133075.243762.90应收账款33.27210441.2034.94营业税金及附加44.9256.6364.8979.38其它应收款28.3635.4737.6751.80262.08295.47350.89451.85预付账款24.6030.7234.8642.66管理货用365.75456.63523.26640.12存货2332.002335.452789.963272.49财务货用-57.99-42.7346.23-50.57其他1139.581304.311343.061670.96资产减值损失-2.250.000.000.005670.006968.968182.019310.31公允价值变动收益0.000.000.000.00长期投资0.000.000.000.00投资净收益28.1335.4640.6349.712477.113810.565032.266153.22营业利润1432.121821.542102.592542.76无形资严441.63511.63576.63636.63营业外收入2.772.002.002.00其他2751262646.762573.122520.46营业外支出8.618.008.008.0012940.71145093116398.2018809.061426.271815.542096.592536.76流动负债1157.351314.671472.481780.43所得税221.44281.87325.51393.85短期借款0.000.000.000.00净利润1204.831533.671771.082142.91应付账款69.34812389.62119.43323.81412.18475.99575.92其他1088.011233.441382.861661.00归属母公司净利润881.031121.491295.091566.99427.02387.02347.02307.02EBITDA1522.542084.402442.682954.17长期借款253.75203.75153.75103.75EPS(元)0.530.680.790.95其他173.27183.2719327203.271584371701.691819.5020874520222023E2024E2025E2560.602972.783448.774024.69营业收入3.63%26.07%14.59%22.33%8795.749834.811129.9312696.92营业利润15.04%27.19%15.43%20.93%12940.71145093116398.2018809.06归属母公司净利润15.92%27.29%1548%20.99%毛利率49.08%49.55%50.04%50.03%20222023E2024E2025E净利率20.68%20.88%21.04%20.81%1126.001846.371812.422101.72ROE10.02%11.40%11.64%12.34%净利润1204.831533.671771.082142.91ROIC9.56%11.18%11.43%12.13%192.14341.04426.95511.6912.24%11.73%11.10%11.10%2.4012.9710.978.97净负债比率13.95%13.29%12.48%12.48%投资损失-28.13-35.46-40.63-49.71流动比率6.285.745.585.34营运资金变动-235.12-11.85-361.95-518.14速动比率4.253.943.663.47其它-10.126.006.006.00总资严周转率0.330.370.380.40-187090-161.54-160537-159629应收帐款周转率128.07255.33149.42215.53-1353.31-1626.00-1626.00-1626.00应付帐款周转率614666.1468.6963.06长期投资-36360.000.000.000.530.680.790.95其他-48124154620.6329.710.681.121.101.28-378.20-135365.345.976.757.71短期借款0.000.000.000.00P/E47.4337.26322726.67长期借款-112.50-50.00-50.00-50.00P/B4.754253.753.29其他-265.70-85.360.971.03EV/EBITDA23.5118.3915.6112.74-1123.15100.47156.08456.46P/S9.817.786.795.55请务必阅读正文最后的中国银河证券股份有限公司免黄声明。